Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010

Influenza and other Respiratory Viruses

Volumn 6, Issue 2, 2012, Pages 142-152

  Ampofo, William K ^a   Baylor, Norman ^b   Cobey, Sarah ^c   Cox, Nancy J ^d   Daves, Sharon ^e   Edwards, Steven ^f   Ferguson, Neil ^g   Grohmann, Gary ^h   Hay, Alan ⁱ   Katz, Jacqueline ^d   Kullabutr, Kornnika ^j   Lambert, Linda ^k   Levandowski, Roland ^l   Mishra, A C ^m   Monto, Arnold ⁿ   Siqueira, Marilda ^o   Tashiro, Masato ^p   Waddell, Anthony L ^q   Wairagkar, Niteen ^r   Wood, John ^s   Zambon, Maria ^t   Zhang, Wenqing ^r   more..

^a National Influenza Centre   (Ghana)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e US Naval Medical Research Unit No 3 Egypt   (Egypt)

^f Network of Expertise on Animal Influenzas (OFFLU) Steering Committee   (United Kingdom)

^g IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^h THERAPEUTIC GOODS ADMINISTRATION   (Australia)

ⁱ NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^j MINISTRY OF PUBLIC HEALTH   (Thailand)

^k NATIONAL INSTITUTES OF HEALTH   (United States)

^l Freelancer   (United States)

^m National Influenza Centre   (India)

ⁿ UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^o INSTITUTO OSWALDO CRUZ   (Brazil)

^p WHO Collaborating Centre for Reference and Research on Influenza   (Japan)

^q Freelancer   (United Kingdom)

^r WORLD HEALTH ORGANIZATION   (Switzerland)

^s NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^t PUBLIC HEALTH ENGLAND   (United Kingdom)

more..

Author keywords

Influenza vaccine viruses; Vaccine virus selection; WHO recommendations

Indexed keywords

INFLUENZA VACCINE;

ANTIBODY RESPONSE; ANTIGENIC MODULATION; AUTOMATION; AVIAN INFLUENZA VIRUS; CONFERENCE PAPER; CONSULTATION; DIAGNOSTIC ACCURACY; DRUG EFFICACY; EPITOPE MAPPING; GENE SEQUENCE; GENETIC VARIABILITY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA A; INFLUENZA VACCINATION; INFLUENZA VIRUS; MATHEMATICAL MODEL; MOLECULAR DIAGNOSIS; NONHUMAN; PANDEMIC INFLUENZA; PHYLOGENY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SEROEPIDEMIOLOGY; STANDARDIZATION; SWITZERLAND; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION; X RAY CRYSTALLOGRAPHY;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; SWITZERLAND; VACCINATION; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84857050827     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2011.00277.x     Document Type: Conference Paper

References (0)